Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
Encephalopathy and Peripheral Neuropathy Following Diethylene Glycol Ingestion
Neurol 64:1273-1275, Hasbani,M.J.,et al, 2005
Methyl Bromide Intoxication Causes Reversible Symmetric Branstem and Cerebellar MRI Lesions
Neurol 64:1279-1281, Geyer,H.L.,et al, 2005
Neuropathy Resembling CIDP in Patients Receiving Tumor Necrosis Factor-a Blockers
Neurol 64:1468-1470, Richez,C.,et al, 2005
Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005
Prevalence of Leukoencephalopathy in Children Treated for Acute Lymphoblastic Leukemia with High-Dose Methotrexate
AJNR 26:1263-1269, Reddick,W.E.,et al, 2005
Fatal Toxic Leukoencephalopathy: Clinical, Radiological, and Necropsy Findings in Two Patients
JNNP 76:1014-1016, Ryan,A.,et al, 2005
Leukoencephalopathy From "Chasing the Dragon"
Neurol 64:1755, Halloran,O.,et al, 2005
NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005
Malignant Hyperthermia, Update on Susceptibility Testing
JAMA 293:2918-2924,2958, Litman,R.S.&Rosenberg,H., 2005
Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005
Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack
Stroke 36:1366-1371, Koren-Morag,N.,et al, 2005
Components of the Metabolic Syndrome and Risk for First-Ever Acute Ischemic Nonembolic Stroke in Elderly Subjects
Stroke 36:1372-1376, Milionis,H.J.,et al, 2005
Diffusion-Weighted MR Imaging of Early Methotrexate-Related Neurotoxicity in Children
AJNR 26:1686-1689, Fisher,M.J.,et al, 2005
Acute Painful Neuropathy in Thallium Poisoning
Neurol 65:302-304, Kuo,H.-C.,et al, 2005
Association of the Metabolic Syndrome with Intracranial Atherosclerotic Stroke
Neurol 65:296-298,188, Bang,O.Y.,et al, 2005
Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004
Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS
Neurol 62:282-284,168, Saiz,A.,et al, 2004
Cognitive Functions in Survivors of Primary Central Nervous System Lymphoma
Neurol 62:548-555,532, Correa,D.D.,et al, 2004
Cognitive Status and Quality of Life After Treatment for Primary CNS Lymphoma
Neurol 62:544-547,532, Harder,H.,et al, 2004
Therapy for Nerve Agent Poisoning
Arch Neurol 61:649-652, Newmark,J., 2004
Aromatic L-Amino Acid Decarboxylase Deficiency
Neurol 62:1058-1065, Pons,R.,et al, 2004
Recurrent Acroparaesthesia During Febrile Infections
Lancet 363:1698, Bodamer,O.A.,et al, 2004
Chemotherapy as Initial Treatment in Gliomatosis Cerebri
Neurol 63:354-356, Levin,N.,et al, 2004
Initial Chemotherapy in Gliomatosis Cerebri
Neurol 63:270-275,204, Sanson,M.,et al, 2004
Peripheral Neuropathy
Lancet 363:2151-2161, England,J.D. &Asbury,A.K., 2004
Thalidomide Sensory Neurotoxicity
Neurol 62:2291-2293, Cavaletti,G.,et al, 2004
Clinicopath Conf, Anaplastic Oligodendroglioma with Allelic Loss of Chromosomes 1p and 19q
NEJM 351:1875-1882, Case 33-2004, 2004
Tacrolimus Leukoencephalopathy: A Neuropathologic Confirmation
Neurol 63:1132-1133, Lavigne,C.M.,et al, 2004
The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004
Acute Methotrexate Neurotoxicity: Findings on Diffusion-Weighted Imaging and Correlation with Clinical Outcome
AJNR 25:1688-1695, Rollins,N.,et al, 2004
Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping
Nueroradiology 46:978-983, Ahn, K.J.,et al, 2004
Carbon Monoxide Poisoning and Sensorineural Hearing Loss
J Laryngol Otol 117:134-137, Hassan,M.S.,et al, 2003
Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003
Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003
Dramatic Response to Chemotherapy in Oligodendroglial Gliomatosis Cerebri
Neurol 60:151, Louis,E.,et al, 2003
Primary Brain Tumours in Adults
Lancet 361:323-331, Behin,A.,et al, 2003
Practice Parameter: Evaluation of the Child with Global Developmental Delay
Neurol 60:367-380, Shevell,M.,et al, 2003
Neonatal Epileptic Encephalopathy
Lancet 361:1614, Clayton,P.T.,et al, 2003
Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003
Mitochondrial Respiratory-Chain Diseases
NEJM 348:2656-2668, DiMauro,S. &Schon,E.A., 2003
Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003
Clinical Manifestations of Sarin Nerve Gas Exposure
JAMA 290:659-662, Lee,E.C., 2003
Treatment of Primary CNS Lymphoma with Methotrexate and Deferred Radiotherapy: A Report of NABTT 96-07
J Clin Oncol 21:1044-1049, Batchelor,T.,et al, 2003
Biochemical And Clinical Aspects of Methotrexate Neurotoxicity
Chemotherapy 49:92-104, Vezmar,S.,et al, 2003
Acute Carbon Monoxide Poisoning: Diffusion MR Imaging Findings
AJNR 24;1475-1477, Sener,R.N., 2003
MR Imaging and Diffusion-Weighted Imaging Changes in Metronidazole (Flagyl)-Induced Cerebellar Toxicity
AJNR 24:1615-1617, Heaney,C.J.,et al, 2003
Gamma Hydroxybutyrate Intoxication
NEJM 349:1267-1275, Case 30-2003, 2003
Diagnostic Approach in Patients with Symmetric Imaging Lesions of the Deep Gray Nuclei
The Neurologist 9:250-261, Finelli,P.F.&DiMario,Jr,F.J., 2003
Neurotoxocity of Intrathecal Methotrexate: MR Imaging Findings
AJNR 24:1887-1890, Sandoval,C.,et al, 2003